BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 265 filers reported holding BIONTECH SE in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,811,031 | +9.7% | 81,103 | +9.0% | 0.02% | +11.8% |
| Q2 2023 | $8,032,259 | -7.2% | 74,421 | +7.1% | 0.02% | -15.0% |
| Q1 2023 | $8,658,362 | -15.8% | 69,506 | +1.5% | 0.02% | -25.9% |
| Q4 2022 | $10,282,859 | +20.2% | 68,452 | +7.9% | 0.03% | +17.4% |
| Q3 2022 | $8,557,000 | +0.9% | 63,451 | +11.6% | 0.02% | +4.5% |
| Q2 2022 | $8,477,000 | +21.3% | 56,852 | +38.8% | 0.02% | +214.3% |
| Q1 2022 | $6,988,000 | +17.3% | 40,960 | +77.3% | 0.01% | -46.2% |
| Q4 2021 | $5,955,000 | +803.6% | 23,099 | +856.5% | 0.01% | +550.0% |
| Q3 2021 | $659,000 | +31.0% | 2,415 | +7.5% | 0.00% | +100.0% |
| Q2 2021 | $503,000 | – | 2,247 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |